Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001532218-26-000002

CHAIRMAN & CEO gave up 10,313 shares (to pay taxes)

  • CHAIRMAN & CEO acquired 21,327 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanj K · CHAIRMAN & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Exercise or conversion : show line 1 in the form +21,327 81,327 I
2026-04-01 Shares withheld for taxes : show line 2 in the form −10,313 $48.13 $496,365 71,014 I

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2026-04-01 Grant or award : show line 3 in the form Share Option +120,150 120,150 D
2026-04-01 Grant or award : show line 4 in the form Restricted Share Unit +30,050 30,050 D
2026-04-01 Grant or award : show line 5 in the form Performance Share Unit +60,100 60,100 D
2026-04-01 Exercise or conversion : show line 6 in the form Restricted Share Unit −6,481 6,481 D
2026-04-01 Exercise or conversion : show line 7 in the form Restricted Share Unit −6,237 12,475 D
2026-04-01 Exercise or conversion : show line 8 in the form Restricted Share Unit −8,609 25,826 D
Loading xslF345X06/form4-04032026_080457.xml…